The secondary alcohol and aglycone metabolites of doxorubicin alter metabolism of human erythrocytes

Brazilian Journal of Medical and Biological Research

F. Misiti²  B. Giardina²  A. Mordente²  M.e. Clementi¹ 

[1] ,Università Cattolica del Sacro Cuore Facoltà di Medicina e Chirurgia Istituto di Biochimica e Biochimica ClinicaRome,Italy

关键词: Anthracyclines;    Doxorubicinol;    Doxorubicin;    Aglycone metabolite;    Pentose phosphate pathway;    [13C]-NMR spectroscopy;    Hemoglobin;   

DOI  :  10.1590/S0100-879X2003001200005

来源: SciELO

【 摘 要 】

Anthracyclines, a class of antitumor drugs widely used for the treatment of solid and hematological malignancies, cause a cumulative dose-dependent cardiac toxicity whose biochemical basis is unclear. Recent studies of the role of the metabolites of anthracyclines, i.e., the alcohol metabolite doxorubicinol and aglycone metabolites, have suggested new hypotheses about the mechanisms of anthracycline cardiotoxicity. In the present study, human red blood cells were used as a cell model. Exposure (1 h at 37ºC) of intact human red blood cells to doxorubicinol (40 µM) and to aglycone derivatives of doxorubicin (40 µM) induced, compared with untreated red cells: i) a ~2-fold stimulation of the pentose phosphate pathway (PPP) and ii) a marked inhibition of the red cell antioxidant enzymes, glutathione peroxidase (~20%) and superoxide dismutase (~60%). In contrast to doxorubicin-derived metabolites, doxorubicin itself induced a slighter PPP stimulation (~35%) and this metabolic event was not associated with any alteration in glutathione reductase, glutathione peroxidase, catalase or superoxide dismutase activity. Furthermore, the interaction of hemoglobin with doxorubicin and its metabolites induced a significant increase (~22%) in oxygen affinity compared with hemoglobin incubated without drugs. On the basis of the results obtained in the present study, a new hypothesis, involving doxorubicinol and aglycone metabolites, has been proposed to clarify the mechanisms responsible for the doxorubicin-induced red blood cell toxicity.

【 授权许可】

CC BY   
 All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License